Kenneth Bender, PharmD, MA

Two gene therapy techniques in separate, concurrently published trials demonstrate clinical success in mitigating monogenic hemoglobinopathies.

In a rare clinical trial, stem cell transplantation appeared to provide greater protection against MS progression than DMT.